These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1747426

  • 1. [Immunoenzyme determination of the total level of ceruloplasmin in the serum from patients with hepatocerebral dystrophy].
    Saenko EL, Skorobagat'ko OV, Iaropolov AI.
    Biokhimiia; 1991 Sep; 56(9):1640-6. PubMed ID: 1747426
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Value of an enzymatic assay for the determination of serum ceruloplasmin.
    Macintyre G, Gutfreund KS, Martin WR, Camicioli R, Cox DW.
    J Lab Clin Med; 2004 Dec; 144(6):294-301. PubMed ID: 15614251
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Plasma non-ceruloplasmin copper in hepatocerebral dystrophy (criterion for the diagnosis and evaluation of cuprogogue therapy)].
    Botvinnik VS, Lekar' PG, Makarova VA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981 Dec; 81(3):334-7. PubMed ID: 7257674
    [Abstract] [Full Text] [Related]

  • 8. [Protective effect rendered by human ceruloplasmin on erythrocytes in hepatocerebral dystrophy].
    Saenko EL, Skorobogat'ko OV, Mzhel'skaia TI, Ivanova-Smolenskaia IA, Markova ED, Basevich VV.
    Biokhimiia; 1989 Oct; 54(10):1617-22. PubMed ID: 2605268
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Interaction of molecular forms of ceruloplasmin with specific membrane receptors from healthy persons and patients with hepatolenticular degeneration].
    Puchkova LV, Verbina IA, Gaĭtskoki VS, Neĭfakh SA.
    Biokhimiia; 1991 Dec; 56(12):2261-9. PubMed ID: 1666959
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of the blood serum from subjects with hepatolenticular degeneration on the ceruloplasmin activity in the serum of normal and schizophrenic subjects].
    Puzyński S, Kalinowski A.
    Neurol Neurochir Psychiatr Pol; 1966 Aug; 16(8):885-90. PubMed ID: 5969522
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Isolation and physico-chemical properties of rat ceruloplasmin].
    Zakharova ET, Vasil'ev VB, Gorbunova VN, Shavlovskiĭ MM.
    Biokhimiia; 1983 Oct; 48(10):1709-20. PubMed ID: 6639990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.